Billed twice
Published 1 October 2026
On the morning of 30 September 2026 - the same week the insurance market was repricing commission caps - the Supreme Court of India looked at the other side of the health business and called it carnage. A bench hearing petitions on medicine-price regulation was told that a cancer drug supplied to retailers for Rs.2,700 carries a printed MRP of Rs.27,000 - a tenfold markup - and that corporate hospitals make inpatients buy medicines only from their own pharmacies at the printed price. The court's words, not this file's: "This is carnage. Plain and simple."
The bench of Justices Vikram Nath and Sandeep Mehta did not stop at the markup. "Corporate hospitals don't spare anyone," the judges observed from the bench. "They won't allow even the dead body to be taken out." They asked the Centre why a uniform margin - the figure floated in court was 16% on MRP - should not apply to all medicines, essential or not, and asked it to examine the mandatory in-house pharmacy rule. The market's answer came within the hour: hospital stocks fell 4-6% in morning trade - Apollo, Max and Yatharth down 4-6%, Fortis down 5.2%, KIMS down 3.8%, Aster DM down 4.2%. These are observations in a hearing, not an enacted cap; the Drug Prices Control Order covers scheduled drugs, and the court was pressing the government to act. But notice what the exchange did: it priced, instantly, the possibility that the hospital revenue model might be regulated - exactly as it had priced the commission model the week before. Two courtrooms of risk, one business model: the bill.
Now put the insurance card on the counter, because that is where the two machines meet. The Indian hospital business runs on a simple price discovery: find out what the patient can pay - or what his insurer can be billed - before you find out what he has. The industry's own numbers show the result. Medical inflation runs at roughly triple the general rate: medical trend reached 12% in 2024 and is projected at 13% in 2025, against general inflation of about 4-5%. A bill growing 13% a year doubles in under six years. The sum insured you bought five years ago has quietly halved. That is not an accident of medicine; it is a pricing system in which the largest bills are paid by institutions that negotiate after the treatment, not before it.
The rates war the patient never sees
In August and September 2025, the war behind that pricing broke into the open. The Association of Healthcare Providers of India - representing thousands of hospitals - told its members to stop giving cashless treatment to policyholders of two large insurers, demanding higher tariffs; the insurers refused a blanket hike and offered hospital-by-hospital negotiation instead. The General Insurance Council formally asked the hospitals' association to withdraw its advisory, citing the risk to patients. Days later, Star Health and the association ended their dispute and cashless service resumed. Read the episode for what it is: the hospital lobby and the insurer lobby fighting, in public, over the price list - and the only party with no seat at the table is the patient whose card stopped working at admission. Cashless treatment, the single reason most families buy health insurance, turned out to be a private treaty between two industries, revocable at will.
The arithmetic of who absorbs all this is in the regulator's ledger. Health insurers paid Rs.94,247.60 crore in claims in 2024-25 - the money that actually reached hospital bills. Where the bill was padded, the insurer's claims team trimmed it back, and the difference between what the hospital demanded and what the insurer paid did not vanish. It landed on the family, as "non-payable items," "difference in room rent," "consumables not covered" - the fine-print line items that turn an insured hospitalization into a five-figure out-of-pocket surprise. The hospital blames the insurer's rates, the insurer blames the hospital's bills, the premium rises 13% a year to fund the fight, and the only party without a lobby pays both sides. The Supreme Court's word for the markup applies to the whole arrangement, and the court said it the week this file was written: carnage, plain and simple.
The two price lists
Ask anyone who has sat through a hospital admission in India about the moment the insurance card comes out, and they will tell you what changes: the estimate. The room category migrates upward. The consumables multiply. The package arrives pre-padded with items the uninsured patient's bill never carries, priced at rates the pharmacy outside the gate undercuts by half. The Supreme Court's September hearing put the extreme end of this on the record - a medicine supplied at Rs.2,700 carrying a printed MRP of Rs.27,000, and hospitals insisting the inpatient buy it, at the printed price, from the hospital's own chemist. The bench's suggestion of a uniform 16% margin on all medicines was aimed at exactly this: a pricing system in which the same pill has two prices, and the patient's insurance status decides which one appears.
The insurer's countermove is the tariff negotiation, and it is the reason the cashless network exists at all: insurers agree package rates with network hospitals, and the hospital's rack rate - the one the uninsured patient pays - becomes the fiction against which the "negotiated" rate is a discount. Both numbers are theater. The rack rate is set high enough to make the negotiated rate look like a victory; the negotiated rate rises every renewal at the medical-inflation clip; and the uninsured patient, who has no negotiator, pays the fiction in full. This is the part of the health business no reform has touched: not the claims ratio, not the commission cap, but the simple absence of a real price for care, discoverable before the emergency, the same for the insured and the uninsured alike. The court called the markup carnage. The deeper wound is that there is no price list at all - only a negotiation the patient never attends, between two industries that both bill him.
What the bill looks like from the bed
The cashless denial is the moment the two machines - hospital and insurer - show the patient their real relationship. It arrives as a sentence at the admission desk: the insurer has not approved the estimate; please deposit Rs.2 lakh and claim reimbursement later. The family is now financing the gap between two industries mid-emergency, and the reasons given live in the vocabulary this chapter has documented: the room category exceeds eligibility, the treatment awaits pre-authorization, the hospital is "under query" with the insurer, the TPA has sought documents the family does not know how to produce. Each reason has a defensible version. In aggregate they describe a system in which the word "cashless" - the single most marketed word in Indian health insurance - is a permission, revocable at the counter, rather than a promise. The standoffs of 2025 made it literal: when AHPI's members suspended cashless for two insurers' policyholders, patients of those insurers paid deposits at hospitals they had chosen precisely because their card worked there. The treaty was between the industries. The hostages were the policyholders.
The reimbursement route that follows is its own education. The family pays the rack rate - the fiction price, the one without a negotiator - and then spends months submitting bills, discharge summaries, investigation reports, and clarification letters to recover what the policy owes, minus the deductions they will discover line by line: the consumables excluded, the room-rent proportionate cut, the sub-limit on the procedure, the "reasonable and customary" reduction, a phrase that means the insurer's price, not the hospital's. The refund that finally arrives is the bill minus the machine's toll, and the family's conclusion - "insurance never pays in full" - enters the neighborhood's folklore as another reason not to buy it. The machine thereby taxes even its honest claims: it converts them, at the counter and in the paperwork, into the distrust that keeps penetration at 3.7%, and then cites the distrust as the market failure its commissions are needed to overcome. The circle is perfect. The patient paid for every arc of it.